2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Suspended
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Hematologic Neoplasms
4
Neutropenia
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Lymphoma
2
Leukemia
2
Infections
2
Fever
2
Febrile Neutropenia
2
Waldenstrom Macroglobulinemia
1
Urinary Tract Infections
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Respiratory Distress Syndrome
1
Renal Insufficiency, Chronic
1
Recurrence
1
Pulmonary Arterial Hypertension
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumonia, Viral
1
Pneumonia
1
Pancreatic Neoplasms
1
Pancreatic Diseases
1
Pain
1
Interventions
tocilizumab
1
lopinavir-ritonavir drug combination
1
Piperacillin, Tazobactam Drug Combination
1
Oxygen Inhalation Therapy
1
Methylprednisolone
1
Lopinavir
1
Hydroxychloroquine
1
Heparin, Low-Molecular-Weight
1
Azithromycin
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pneumonia, Viral
×
Piperacillin, Tazobactam Drug Combination
×
Clear all
NCT04394182
2022-03-29
ULTRA-COVID
Fundacion GenesisCare
Phase NA
Suspended
15 enrolled